Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly common. While it can be a non-progressive disorder with minimal impact, for some people, it develops into a serious disorder with significant implications for their life and health. This article outlines the pa...
Alimentary Pharmacology And Therapeutics. 36(9): 815-823.Yilmaz, Y. Review article: Is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment. Pharmacol. Therap. 2012, 36, 815-823....
Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are additional findings of portal and lobular inflammation and hepatocyte injury (which characterize nonalcoholic st...
Nonalcoholic fatty liver disease (NAFLD) may be the most common liver disease in the world, with a high prevalence in the obese, type 2 diabetic populations, and it is probably underestimated as a cause for cirrhosis. Clinicopathologically, it represents a wide spectrum of histologic abnormalities...
This Review focuses on the adverse effect of nonalcoholic fatty liver disease (NAFLD) on the risk of chronic vascular complications of diabetes mellitus. The putative pathophysiological mechanisms by which NAFLD might contribute to the development and pr
Non-alcoholic fatty liver disease (NAFLD), the most common cause of liver disease, affects approximately 75 to 100 million Americans. Patients with concurrent NAFLD and type 2 diabetes mellitus have a higher risk of progressing to advanced fibrosis and non-alcoholic steatohepatitis compared to non-...
[2] Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. Erratum in: JAMA. 2015 Oct 13;314(14):1521. PMID: 26057287. [3] Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the ...
Key words: nonalcoholic fatty liver disease,targeted therapy,pharmacological target Cite this article NIU Chunyan, SHI Yongqiang, CHEN Yue..Targeted therapeutic drugs for nonalcoholic fatty liver disease:A review of literature[J]. The Journal of Practical Medicine, 2022, 38(11): 1439-1442....
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal serum aminotransferase levels in both developed and developing countries. Pat... A Ahmed,RJ Wong,SA Harrison - 《Clinical Gastroenterology & Hepato...
Rapid Review Quiz: Nonalcoholic Fatty Liver Disease (NAFLD) Fast Five Quiz: How Would You Manage MASLD and MASH? Antidiabetic Combination Therapy for Type 2 Diabetes Fast Five Quiz: How Much Do You Know About Metabolic Dysfunction–Associated Steatohepatitis? Fast Five Quiz: Metabolic Dysfunction...